1887

Abstract

Previous studies using transgenic mice with B-cell expression of LMP2A demonstrated that LMP2A drives B-cell development and survival signal in the absence of normal B-cell receptor (BCR) signal transduction. To determine if LMP2A may have similar effects in epithelial differentiation, six transgenic murine lines were constructed and analysed with LMP2A expression directed to the epidermis by a keratin 14 (K14) promoter cassette. LMP2A protein expression was verified by immunofluorescence and immunoprecipitation of skin samples using LMP2A-specific antibodies. To evaluate the effects of LMP2A expression on epidermal differentiation, immunofluorescence and histochemistry were performed on tongue and tail samples of transgenic mice and their wild-type littermate controls using differentially expressed keratins. The analysis indicated that LMP2A does not alter the normal epithelial differentiation program in the epithelia of K14–LMP2A transgenic mice.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-9-2245
2000-09-01
2024-11-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/9/0812245a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-9-2245&mimeType=html&fmt=ahah

References

  1. Burkhardt A. L., Bolen J. B., Kieff E., Longnecker R. 1992; An Epstein–Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. Journal of Virology 66:5161–5167
    [Google Scholar]
  2. Caldwell R. G., Wilson J. B., Anderson S. J., Longnecker R. 1998; Epstein–Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9:405–411
    [Google Scholar]
  3. Caldwell R. G., Brown R. C., Longnecker R. 2000; Epstein–Barr virus LMP2A-induced B-cell survival in two unique classes of EuLMP2A transgenic mice. Journal of Virology 74:1101–1113
    [Google Scholar]
  4. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869
    [Google Scholar]
  5. Cruchley A. T., Williams D. M., Niedobitek G., Young L. S. 1997; Epstein–Barr virus: biology and disease. Oral Diseases 3:Suppl. 1S156–S163
    [Google Scholar]
  6. Fruehling S., Longnecker R. 1997; The immunoreceptor tyrosine-based activation motif of Epstein–Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235:241–251
    [Google Scholar]
  7. Fruehling S., Lee S. K., Herrold R., Frech B., Laux G., Kremmer E., Grasser F. A., Longnecker R. 1996; Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. Journal of Virology 70:6216–6226
    [Google Scholar]
  8. Fruehling S., Swart R., Dolwick K. M., Kremmer E., Longnecker R. 1998; Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein–Barr virus latency. Journal of Virology 72:7796–7806
    [Google Scholar]
  9. Fuchs E., Byrne C. 1994; The epidermis: rising to the surface. Current Opinion in Genetics & Development 4:725–736
    [Google Scholar]
  10. Guo L., Yu Q. C., Fuchs E. 1993; Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO Journal 12:973–986
    [Google Scholar]
  11. Kaplan K. B., Swedlow J. R., Morgan D. O., Varmus H. E. 1995; c-Src enhances the spreading of src−/− fibroblasts on fibronectin by a kinase-independent mechanism. Genes & Development 9:1505–1517
    [Google Scholar]
  12. Kieff E. 1996; Epstein–Barr virus and its replication. In Fields Virology pp 2343–2396 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  13. Knapp B., Rentrop M., Schweizer J., Winter H. 1987; Three cDNA sequences of mouse type I keratins. Cellular localization of the mRNAs in normal and hyperproliferative tissues. Journal of Biological Chemistry 262:938–945
    [Google Scholar]
  14. Kulwichit W., Edwards R. H., Davenport E. M., Baskar J. F., Godfrey V., Raab-Traub N. 1998; Expression of the Epstein–Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proceedings of the National Academy of Sciences, USA 95:11963–11968
    [Google Scholar]
  15. Longnecker R. 1998; Molecular biology of Epstein–Barr virus. In Human Tumor Viruses pp 133–172 Edited by McCance D. Washington, DC: American Society for Microbiology;
    [Google Scholar]
  16. Miller C. L., Lee J. H., Kieff E., Longnecker R. 1994; An integral membrane protein (LMP2) blocks reactivation of Epstein–Barr virus from latency following surface immunoglobulin crosslinking. Proceedings of the National Academy of Sciences, USA 91:772–776
    [Google Scholar]
  17. Miller C. L., Burkhardt A. L., Lee J. H., Stealey B., Longnecker R., Bolen J. B., Kieff E. 1995; Integral membrane protein 2 of Epstein–Barr virus regulates reactivation from latency through dominant negative effects on protein tyrosine kinases. Immunity 2:155–166
    [Google Scholar]
  18. Moll R., Franke W. W., Schiller D. L., Geiger B., Krepler R. 1982; The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11–24
    [Google Scholar]
  19. Morgan P. R., Su L. 1994; Intermediate filaments in oral neoplasia. I. Oral cancer and epithelial dysplasia. European Journal of Cancer, Part B, Oral Oncology 30:160–166
    [Google Scholar]
  20. Raab-Traub N. 1992; Epstein–Barr virus and nasopharyngeal carcinoma. Seminars in Cancer Biology 3:297–307
    [Google Scholar]
  21. Rickinson A. B., Kieff E. 1996; Epstein–Barr virus. In Fields Virology pp 2397–2446 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  22. Scholle F., Longnecker R., Raab-Traub N. 1999; Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein–Barr virus latent membrane protein 2: a role for C-terminal Src kinase. Journal of Virology 73:4767–4775
    [Google Scholar]
  23. Stoler A., Kopan R., Duvic M., Fuchs E. 1988; Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. Journal of Cell Biology 107:427–446
    [Google Scholar]
  24. Thomas S. M., Brugge J. S. 1997; Cellular functions regulated by Src family kinases. Annual Review of Cell and Developmental Biology 13:513–609
    [Google Scholar]
  25. Turksen K., Kupper T., Degenstein L., Williams I., Fuchs E. 1992; Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proceedings of the National Academy of Sciences, USA 89:5068–5072
    [Google Scholar]
  26. Vassar R., Hutton M. E., Fuchs E. 1992; Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Molecular and Cellular Biology 12:4643–4653
    [Google Scholar]
  27. Weiss A., Littman D. R. 1994; Signal transduction by lymphocyte antigen receptors. Cell 76:263–274
    [Google Scholar]
  28. Weiss R. A., Eichner R., Sun T. T. 1984; Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. Journal of Cell Biology 98:1397–1406
    [Google Scholar]
  29. Wilson J. B., Weinberg W., Johnson R., Yuspa S., Levine A. J. 1990; Expression of the BNLF-1 oncogene of Epstein–Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315–1327
    [Google Scholar]
  30. Wilson J. B., Bell J. L., Levine A. J. 1996; Expression of Epstein–Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO Journal 15:3117–3126
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-81-9-2245
Loading
/content/journal/jgv/10.1099/0022-1317-81-9-2245
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error